Molecular diagnostics is used to measure and detect the presence of genetic material associated with specific diseases, and applied as a tool by healthcare professionals and patients to improve clinical outcomes and medical decisions. Asia Genomics, a Singapore-based molecular diagnostics company specialising in clinical genomics in areas relating to genetic diseases was seeking to advance its in-house capabilities and know-how particularly in cancer diagnostics.
In early 2015, IPI organised a round-table discussion on Precision Medicine with Dr Edison Liu, President & CEO of Jackson Laboratory as the keynote speaker. Jackson Laboratory, is an independent, non-profit biomedical research institution headquartered in the United States. Following the round-table, Asia Genomics and Jackson Lab continued their discussions on potential technology transfer of cancer panel molecular diagnostics and the provision of such services to Asian patients. A collaboration was formalised in August 2016, where Asia Genomics and Jackson Laboratory will exchange know-how on the positioning of cancer panel in Asia and provide educational tools to facilitate practicing clinicians to understand this new area of technology.
“Asia Genomics is pleased to be connected with Jackson Laboratory through IPI’s wide network of technology partners. The collaboration will strengthen our diagnostics capabilities and also set the stage for future collaboration in the area of technology transfer of lab-based technologies and bioinformatics,” said Dr Wong Mun Yew, Founder and CEO of Asia Genomics.
Asia Genomics, operating at the forefront of molecular diagnostics in Singapore, recognised the growing importance of precision medicine and the need for advanced tools to detect and measure genetic material associated with specific diseases. As cancer rates rise and the demand for personalised healthcare increases, the ability to offer cutting-edge cancer diagnostics became a strategic imperative for the company. However, Asia Genomics faced limitations in its in-house capabilities and know-how, particularly in the rapidly evolving field of cancer molecular diagnostics. The company sought to bridge this gap by accessing advanced technologies and expertise that could accelerate the development and deployment of new diagnostic solutions tailored to the Asian market. To remain competitive and deliver improved clinical outcomes, Asia Genomics needed to collaborate with leading international research institutions to facilitate technology transfer, knowledge exchange, and the adoption of best practices in cancer panel diagnostics. This would enable the company to provide more comprehensive and effective diagnostic services to healthcare professionals and patients across the region.
IPI Singapore facilitated a strategic connection between Asia Genomics and Jackson Laboratory by organising a round-table discussion on Precision Medicine in early 2015, featuring Dr Edison Liu, President & CEO of Jackson Laboratory, as the keynote speaker. This event provided a platform for Asia Genomics to engage directly with Jackson Laboratory, a renowned independent, non-profit biomedical research institution based in the United States. Following the round-table, IPI Singapore continued to support the engagement by enabling further discussions between Asia Genomics and Jackson Laboratory on the potential technology transfer of cancer panel molecular diagnostics. This culminated in a formalised collaboration in August 2016, where both organisations agreed to exchange know-how on the positioning of cancer panel diagnostics in Asia and to develop educational tools aimed at helping clinicians understand and adopt this advanced technology. Through IPI's facilitation, Asia Genomics gained access to Jackson Laboratory's expertise, strengthening its diagnostic capabilities and paving the way for future technology transfer and bioinformatics initiatives.
"Asia Genomics is pleased to be connected with Jackson Laboratory through IPI’s wide network of technology partners. The collaboration will strengthen our diagnostics capabilities and also set the stage for future collaboration in the area of technology transfer of lab-based technologies and bioinformatics."
Asia Genomics is a Singapore-based molecular diagnostics company specialising in clinical genomics, particularly in the area of genetic diseases. The company sought to enhance its in-house expertise and capabilities, especially in the field of cancer diagnostics, to better serve healthcare professionals and patients across Asia.